Pelthos Therapeutics Inc. (PTHS) Misses Q4 EPS by 633c
Tweet
Share
E-mailGet Alerts PTHS Hot Sheet
Join SI Premium – FREE
Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q4 EPS of ($6.87), $6.33 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $9.39 million.
For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
